Lifevantage Corp

LFVN · XNAS

CIK 849146fmd_1YRE8YTEQ3MKFXWHJSBBBKT4SXManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2026, 65 periods

Income Statement · Annual · Millions · USD
Line item	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Total revenues	199	203	226	233	220	206	213	200	229	183
Cost of revenue	33	35	38	38	38	38	43	41	45	41
Gross profit	166	168	188	195	182	168	170	159	184	142
Research and development	1	1	1	1	1	1	1	1	1	1
Selling, general and administrative	65	60	70	68	61	63	71	68	69	58
Total operating expenses	162	158	178	179	164	161	166	154	171	136
Operating income	4	10	10	15	18	8	4	4	12	6
Interest expense	1	0	0	0	0	0	(0)	(0)	–	–
Other non-operating income (expense)	(2)	(1)	(1)	(1)	(0)	(3)	(0)	0	0	(0)
Income before taxes	3	10	9	15	17	5	4	4	12	6
Income tax expense	1	4	2	3	4	2	1	1	2	1
Net income from continuing operations	2	6	7	12	13	3	3	3	10	5
Net income	2	6	7	12	13	3	3	3	10	5